On Cancer

and/or

102 Blog posts found

Finding

Why Do Some People Beat the Odds against Pancreatic Cancer?

Scientists think they now understand why some people with pancreatic cancer survive for many years. Hint: It involves the immune system.

An illustration of the human pancreas

In the Lab

Why Do Immune Checkpoint Inhibitors Work for Only Some People with Cancer?

Learn about why checkpoint inhibitors, a class of immunotherapy drugs, 
is paying off — but only for some patients.

MSK physician­scientist Luis Diaz

In the Clinic

Genetic ‘Scars’ Provide Clues for Tailoring Cancer Treatment

For the first time, scientists have determined the extent of DNA repair deficiencies across cancer types. Learn what it means for patients.

Image of DNA helix with sequence in the background

In the Clinic

Reduced Radiation Dose for Neuroblastoma Could Spare Children from Complications Later

Learn how MSK doctors are exploring the use of less radiation in neuroblastoma treatment so children can avoid side effects.

Smiling female physician, sitting on right, holding stethoscope against abdomen of blond girl

In the Clinic

Low-Dose Radiation a Possible “Game Changer” for Treating HPV-Positive Throat Cancer

An MSK study has shown that HPV-related head and neck cancer can be treated with a sharply reduced radiation dose to prevent side effects.

Female physician in white coat sitting at screen that shows medical image.

Finding

Making an IMPACT: MSK’s Gene-Sequencing Test Reveals New Findings about Hereditary Cancer Risk

An analysis of germline DNA in people with advanced cancer finds that inherited mutations may be more common than expected in this group.

Kenneth Offit and Vijai Joseph

In the Clinic

MSK Study Bolsters Use of Active Surveillance for Papillary Thyroid Cancer

New findings support the use of active surveillance rather than surgery for papillary thyroid cancer.

Doctor Michael Tuttle in white coat examining female patient.

Announcement

FDA Approves First CAR T Cell Therapy for Leukemia

Children, teens, and young adults with leukemia that have stopped responding to chemotherapy are the first eligible to receive the new treatment.

Pediatric oncologist Kevin Curran with CAR T patient Esmeralda Pineda

Announcement

FDA Approves Enasidenib (Idhifa), a First-of-Its-Kind Drug, for Advanced Blood Cancer

A new treatment option for people with acute myeloid leukemia is available, and it works in an unconventional way.

Acute myeloid leukemia cells under a microscope

Perspective

MSK’s Vision to Transform Lymphoma Treatment

Anas Younes, Chief of the Lymphoma Service, details MSK’s ambitious strategy for advancing lymphoma therapies.

Anas Younes, Chief of the Lymphoma Service at MSK